Newsroom

Chief Talent and People Solutions Officer Tripti Jha’s mother prioritized her learning in a rural region of India with limited opportunities for girls.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.

Novartis researchers aim to preserve kidney function – and quality of life – for patients.

Novartis researchers are using data to accelerate drug development.

These stories offer a glimpse into the lives of people touched by a new era of medicine.

Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Dr. Theophile Tuyisabe is one of only 18 ophthalmologists in Rwanda. We spoke with him about how he does it.

Explaining Chagas disease through the stories of patients in Latin America.

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.